Published in Orphanet J Rare Dis on March 26, 2007
The molecular basis of pulmonary alveolar proteinosis. Clin Immunol (2010) 1.54
Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis (2013) 0.97
Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr (2011) 0.94
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. Orphanet J Rare Dis (2010) 0.86
Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy. J Thorac Imaging (2009) 0.83
Whole lung lavage of nine children with pulmonary alveolar proteinosis: experience in a tertiary lung center. Iran J Pediatr (2013) 0.81
SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance. Orphanet J Rare Dis (2009) 0.78
Pulmonary alveolar proteinosis in a cat. BMC Vet Res (2015) 0.76
Lung involvement in children with lysinuric protein intolerance. J Inherit Metab Dis (2014) 0.76
Pulmonary alveolar proteinosis: a case report and world literature review. Respirol Case Rep (2016) 0.75
Pulmonary alveolar proteinosis. N Engl J Med (1958) 7.24
Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med (2002) 5.23
Pulmonary alveolar proteinosis. N Engl J Med (2003) 4.93
Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med (1999) 3.36
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J (2004) 2.07
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet (1999) 1.65
Lysinuric protein intolerance with chronic interstitial lung disease and pulmonary cholesterol granulomas at onset. J Pediatr (1993) 1.52
SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet (1999) 1.50
Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism. Lancet (1965) 1.50
Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Thorax (2005) 1.22
Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients. Hum Pathol (1994) 1.21
Pulmonary alveolar proteinosis in children. Paediatr Respir Rev (2004) 1.16
The molecular bases of cystinuria and lysinuric protein intolerance. Curr Opin Genet Dev (2001) 1.15
Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation. Pediatr Pathol (1992) 1.15
Pulmonary manifestations in lysinuric protein intolerance. Chest (1993) 0.95
Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance. J Pediatr (2004) 0.93
Role of haematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance. Eur J Pediatr (1993) 0.93
Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods. Am J Respir Crit Care Med (1996) 0.91
Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course. J Pediatr (1995) 0.90
Whole lung lavage. Monaldi Arch Chest Dis (1995) 0.87
A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency. J Inherit Metab Dis (1991) 0.86
Increased NO production in lysinuric protein intolerance. J Inherit Metab Dis (2005) 0.86
Long-term survival of paediatric patients with pulmonary alveolar proteinosis treated with lung lavage. Eur Respir J (2005) 0.82
Abnormal pulmonary macrophages in lysinuric protein intolerance. Ultrastructural, morphometric, and x-ray microanalytic study. Arch Pathol Lab Med (1994) 0.80
Necropsy findings in lysinuric protein intolerance. J Clin Pathol (1996) 0.78
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med (2007) 5.31
Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood (2009) 2.79
Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med (2009) 1.58
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med (2015) 1.52
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol (2006) 1.49
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev (2009) 1.37
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol (2006) 1.25
Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med (2010) 1.21
Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med (2008) 1.20
Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges. Multidiscip Respir Med (2012) 1.18
MET mutations in cancers of unknown primary origin (CUPs). Hum Mutat (2010) 1.13
Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med (2010) 1.10
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2003) 1.10
Therapy options in pulmonary alveolar proteinosis. Ther Adv Respir Dis (2010) 1.09
Laboratory diagnosis of alpha1-antitrypsin deficiency. Transl Res (2007) 1.08
α₁-Antitrypsin level and pheno/genotypes. Chest (2013) 1.07
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation (2004) 1.02
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. J Cancer Res Clin Oncol (2013) 1.02
Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies. Respir Med (2011) 1.02
Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res (2004) 1.02
SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem (2008) 1.00
Whole lung lavage: a unique model for ultrasound assessment of lung aeration changes. Intensive Care Med (2010) 0.98
Assessment of emphysema in COPD: a functional and radiologic study. Chest (2004) 0.98
Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax (2012) 0.98
Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis (2013) 0.97
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes. Cytokine (2002) 0.97
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. PLoS Genet (2013) 0.97
HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.97
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res (2007) 0.96
Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. Clin Chem (2006) 0.95
Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respir Res (2008) 0.94
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 0.93
Disaturated-phosphatidylcholine and surfactant protein-B turnover in human acute lung injury and in control patients. Respir Res (2011) 0.91
Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol (2009) 0.90
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. Electrophoresis (2004) 0.90
Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report. Orphanet J Rare Dis (2009) 0.90
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis (2004) 0.89
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. Pathol Res Pract (2011) 0.88
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. Diagn Mol Pathol (2004) 0.87
Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics (2009) 0.87
Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med (2005) 0.87
Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol (2002) 0.87
Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev Proteomics (2008) 0.86
Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med (2002) 0.86
Surfactant-associated protein B kinetics in vivo in newborn infants by stable isotopes. Pediatr Res (2005) 0.86
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. Orphanet J Rare Dis (2010) 0.86
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res (2011) 0.85
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. Respir Med (2013) 0.85
Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med (2006) 0.85
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). Diagn Mol Pathol (2005) 0.84
The rapid FEV(1) decline in chronic obstructive pulmonary disease is associated with predominant emphysema: a longitudinal study. COPD (2012) 0.84
Caveolin-1 as a promoter of tumour spreading: when, how, where and why. J Cell Mol Med (2013) 0.84
Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS One (2012) 0.83
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD. Eur J Clin Invest (2013) 0.83
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J Respir Cell Mol Biol (2008) 0.83
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model. Respir Res (2007) 0.83
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. Respir Res (2005) 0.83
Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS. Int J Mol Sci (2012) 0.83
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. Eur Respir J (2012) 0.82
Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset. J Heart Lung Transplant (2007) 0.82
Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. J Sep Sci (2007) 0.81
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.81
Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship. Am J Physiol Lung Cell Mol Physiol (2004) 0.81
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. PLoS One (2012) 0.81
Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. Orphanet J Rare Dis (2012) 0.80
Early response of gene clusters is associated with mouse lung resistance or sensitivity to cigarette smoke. Am J Physiol Lung Cell Mol Physiol (2008) 0.80
Peripheral blood progenitor cell mobilization and collection in 42 patients with primary systemic amyloidosis. Transfusion (2005) 0.80
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. Pulm Med (2011) 0.80
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype. Biochem Pharmacol (2011) 0.80
Clinical utility gene card for: α-1-antitrypsin deficiency. Eur J Hum Genet (2011) 0.80
Synthesis and cytotoxicity properties of amiodarone analogues. Eur J Med Chem (2007) 0.79
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. J Proteomics (2008) 0.79
Surfactant protein B amount and kinetics in newborn infants: an optimized procedure. J Mass Spectrom (2012) 0.79
Different genotypes in a large Italian family with recurrent hereditary fructose intolerance. Eur J Gastroenterol Hepatol (2008) 0.79
Surfactant protein C metabolism in human infants and adult patients by stable isotope tracer and mass spectrometry. Anal Bioanal Chem (2014) 0.78
Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. Respir Care (2011) 0.78
Impaired surfactant protein B synthesis in infants with congenital diaphragmatic hernia. Eur Respir J (2012) 0.78
Developing a genomic-based point-of-care diagnostic system for rheumatoid arthritis and multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc (2009) 0.78
[AGE receptor: a novel pro-inflammatory pathway for chronic respiratory disorders?]. Recenti Prog Med (2008) 0.78
Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD. COPD (2011) 0.77
Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer. Pulm Pharmacol Ther (2010) 0.77
Advances in proteomic techniques for biomarker discovery in COPD. Expert Rev Clin Immunol (2011) 0.77
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. Electrophoresis (2005) 0.77
Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance. Mol Genet Metab (2012) 0.77
The use of degrees of certainty to evaluate knowledge. Patient Educ Couns (2003) 0.76
Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes. J Cancer (2011) 0.75
CR1 gene polymorphism in Finland. Respir Med (2005) 0.75
Lung surfactant, asthma, and allergens: a story in evolution. Am J Respir Crit Care Med (2004) 0.75
Comment on 'CFTR gene mutations in sarcoidosis'. Eur J Hum Genet (2003) 0.75